Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Examining a New Scale for Evaluating Taste in Children (TASTY).

Wagner JA, Pabon G, Terrill D, Abdel-Rahman SM.

J Pediatr Pharmacol Ther. 2020;25(2):131-138. doi: 10.5863/1551-6776-25.2.131.

2.

Validation and human factor analysis study of an infant weight estimation device.

Abdel-Rahman SM, Paul IM, Delmore P, Chen JY, Mills M, Greenberg RG; Best Pharmaceuticals for Children Act – Pediatric Trials Network.

BMC Pediatr. 2020 Jan 22;20(1):30. doi: 10.1186/s12887-020-1933-5.

3.

Mercy TAPE for Calculation-Free Height Estimation in Pediatric Rehabilitation Patients.

Modrcin AC, Luce J, Abdel-Rahman SM.

PM R. 2020 Jan 6. doi: 10.1002/pmrj.12317. [Epub ahead of print]

PMID:
31903703
4.

Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children.

Jiang S, Madrasi K, Samant T, Lagishetty C, Vozmediano V, Chiew A, Abdel-Rahman SM, James LP, Schmidt S.

J Clin Pharmacol. 2019 Dec 4. doi: 10.1002/jcph.1555. [Epub ahead of print]

PMID:
31802503
5.

User-Informed Medical Device Development: A Case Study for Pediatric Malnutrition Assessment.

Thaete K, Rowzer K, Stephens K, Abdel-Rahman SM.

Glob Pediatr Health. 2019 Jul 15;6:2333794X19861575. doi: 10.1177/2333794X19861575. eCollection 2019.

6.

Facilitating Informed Permission/Assent/Consent in Pediatric Clinical Trials.

Abdel-Rahman SM.

Paediatr Drugs. 2019 Aug;21(4):205-214. doi: 10.1007/s40272-019-00347-5.

PMID:
31313103
7.

Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of Acetaminophen.

Jiang S, Vozmediano V, Abdel-Rahman SM, Schmidt S, James LP.

J Clin Pharmacol. 2019 Oct;59(10):1291-1299. doi: 10.1002/jcph.1442. Epub 2019 May 17.

8.

How to Conduct Clinical Trials in Children: A Tutorial.

Shakhnovich V, Hornik CP, Kearns GL, Weigel J, Abdel-Rahman SM.

Clin Transl Sci. 2019 May;12(3):218-230. doi: 10.1111/cts.12615. Epub 2019 Mar 18.

9.

A Weight Estimation Strategy for Preterm and Full-Term Infants.

Abdel-Rahman SM, Paul IM, Delmore P, James L, Fearn L, Atz A, Poindexter B, Al-Uzri A, Lewandowski A, Harper B, Smith PB.

Glob Pediatr Health. 2017 Dec 21;4:2333794X17748775. doi: 10.1177/2333794X17748775. eCollection 2017.

10.

An anthropometric survey of US pre-term and full-term neonates.

Abdel-Rahman SM, Paul IM, Delmore P, James L, Fearn L, Atz AM, Poindexter BB, Al-Uzri A, Lewandowski A, Harper BL, Smith PB; Best Pharmaceuticals for Children Act – Pediatric Trials Network.

Ann Hum Biol. 2017 Dec;44(8):678-686. doi: 10.1080/03014460.2017.1392603. Epub 2017 Nov 7.

11.

Comparative Performance of Pediatric Weight Estimation Techniques: A Human Factor Errors Analysis.

Abdel-Rahman SM, Jacobsen R, Watts JL, Doyle SL, OʼMalley DM, Hefner TD, Dowd MD.

Pediatr Emerg Care. 2017 Aug;33(8):548-552. doi: 10.1097/PEC.0000000000000543.

PMID:
28777773
12.

Baclofen systemic toxicity: Experimental histopathological and biochemical study.

Issa SY, Hafez EM, El-Banna AS, Abdel Rahman SM, AlMazroua MK, El-Hamd MA.

Hum Exp Toxicol. 2018 Apr;37(4):431-441. doi: 10.1177/0960327117712369. Epub 2017 May 31.

PMID:
28565970
13.

Pharmacokinetics of two 6-mercaptopurine liquid formulations in children with acute lymphoblastic leukemia.

Tolbert JA, Bai S, Abdel-Rahman SM, August KJ, Weir SJ, Kearns GL, Neville KA.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26465. Epub 2017 Mar 10.

PMID:
28295989
14.

Pediatric Statin Administration: Navigating a Frontier with Limited Data.

Wagner J, Abdel-Rahman SM.

J Pediatr Pharmacol Ther. 2016 Sep-Oct;21(5):380-403. Review.

15.

Construction of Lambda, Mu, Sigma Values for Determining Mid-Upper Arm Circumference z Scores in U.S. Children Aged 2 Months Through 18 Years.

Abdel-Rahman SM, Bi C, Thaete K.

Nutr Clin Pract. 2017 Feb;32(1):68-76. doi: 10.1177/0884533616676597. Epub 2016 Nov 19.

PMID:
27856693
16.
18.

Genetic Predictors of Susceptibility to Dermatophytoses.

Abdel-Rahman SM.

Mycopathologia. 2017 Feb;182(1-2):67-76. doi: 10.1007/s11046-016-0046-z. Epub 2016 Aug 8.

PMID:
27502504
19.

Pharmacokinetic considerations in treating invasive pediatric fungal infections.

Goldman JL, Abdel-Rahman SM.

Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):645-55. doi: 10.1080/17425255.2016.1181752. Epub 2016 May 5. Review.

PMID:
27111148
20.

Design and Testing of an EHR-Integrated, Busulfan Pharmacokinetic Decision Support Tool for the Point-of-Care Clinician.

Abdel-Rahman SM, Breitkreutz ML, Bi C, Matzuka BJ, Dalal J, Casey KL, Garg U, Winkle S, Leeder JS, Breedlove J, Rivera B.

Front Pharmacol. 2016 Mar 30;7:65. doi: 10.3389/fphar.2016.00065. eCollection 2016.

21.

Intravenous busulfan dose individualization - impact of modeling approach on dose recommendation.

Abdel-Rahman SM, Casey KL, Garg U, Dalal J.

Pediatr Transplant. 2016 May;20(3):443-8. doi: 10.1111/petr.12687. Epub 2016 Feb 8.

PMID:
26854326
22.

Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers: a prospective analysis.

Fadel FI, Elshamaa MF, Abdel-Rahman SM, Thabet EH, Kamel S, Kandil D, Ibrahim MH, El-Ahmady M.

Blood Coagul Fibrinolysis. 2016 Mar;27(2):190-8. doi: 10.1097/MBC.0000000000000417.

PMID:
26829282
23.

Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD.

Brown JT, Abdel-Rahman SM, van Haandel L, Gaedigk A, Lin YS, Leeder JS.

Clin Pharmacol Ther. 2016 Jun;99(6):642-50. doi: 10.1002/cpt.319. Epub 2016 Jan 12.

24.

Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.

Gupta A, Mathad JS, Abdel-Rahman SM, Albano JD, Botgros R, Brown V, Browning RS, Dawson L, Dooley KE, Gnanashanmugam D, Grinsztejn B, Hernandez-Diaz S, Jean-Philippe P, Kim P, Lyerly AD, Mirochnick M, Mofenson LM, Montepiedra G, Piper J, Sahin L, Savic R, Smith B, Spiegel H, Swaminathan S, Watts DH, White A.

Clin Infect Dis. 2016 Mar 15;62(6):761-769. doi: 10.1093/cid/civ991. Epub 2015 Dec 9.

25.

Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forest.

Friesen CA, Schurman JV, Abdel-Rahman SM.

World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):96-104. doi: 10.4292/wjgpt.v6.i4.96.

26.

CD4+CD28null T cells in acute coronary syndrome: lower with ST-elevation myocardial infarction.

Sayed NM, Abdel-Rahman SM, Esmat I, Nammas W.

Scand Cardiovasc J. 2015;49(6):325-30. doi: 10.3109/14017431.2015.1088167. Epub 2015 Sep 16.

PMID:
26375412
27.

Systemic exposure to menthol following administration of peppermint oil to paediatric patients.

Kearns GL, Chumpitazi BP, Abdel-Rahman SM, Garg U, Shulman RJ.

BMJ Open. 2015 Aug 12;5(8):e008375. doi: 10.1136/bmjopen-2015-008375.

28.

Plasma ghrelin and liquid gastric emptying in children with functional dyspepsia consistent with post-prandial distress syndrome.

Hijaz NM, Friesen CA, Schurman JV, Pearce RE, Abdel-Rahman SM.

Neurogastroenterol Motil. 2015 Aug;27(8):1120-6. doi: 10.1111/nmo.12591. Epub 2015 May 12.

PMID:
25962328
29.

Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review.

Wagner J, Abdel-Rahman SM.

Pediatrics. 2015 May;135(5):e1333-6. doi: 10.1542/peds.2014-2578. Review.

30.

Estimating Weight in Children With Down Syndrome.

Talib NJ, Rahm G, Abdel-Rahman SM.

Glob Pediatr Health. 2015 Jan 20;2:2333794X14568450. doi: 10.1177/2333794X14568450. eCollection 2015.

31.

Individualized factor IX dosing in two brothers: application of longitudinal pharmacokinetic modelling to optimize therapeutic benefit.

Brown JT, Wicklund BM, Abdel-Rahman SM.

Haemophilia. 2015 Mar;21(2):e125-7. doi: 10.1111/hae.12593. Epub 2014 Nov 24. No abstract available.

32.

Evaluating the Effectiveness of an Illustrated Permission/Assent Form.

Abdel-Rahman SM.

J Immigr Minor Health. 2015 Oct;17(5):1504-8. doi: 10.1007/s10903-014-0116-6.

PMID:
25274022
33.

Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus).

Rytting E, Wang X, Vernikovskaya DI, Zhan Y, Bauer C, Abdel-Rahman SM, Ahmed MS, Nanovskaya TN.

Drug Metab Dispos. 2014 Oct;42(10):1773-9. doi: 10.1124/dmd.114.058255. Epub 2014 Aug 5.

34.

Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.

Weiner M, Savic RM, Kenzie WR, Wing D, Peloquin CA, Engle M, Bliven E, Prihoda TJ, Gelfond JA, Scott NA, Abdel-Rahman SM, Kearns GL, Burman WJ, Sterling TR, Villarino ME; Tuberculosis Trials Consortium PREVENT TB Pharmacokinetic Group.

J Pediatric Infect Dis Soc. 2014 Jun;3(2):132-45. doi: 10.1093/jpids/pit077. Epub 2014 Jan 16.

PMID:
26625366
35.

Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.

Wiczling P, Liem RI, Panepinto JA, Garg U, Abdel-Rahman SM, Kearns GL, Neville KA.

J Clin Pharmacol. 2014 Sep;54(9):1016-22. doi: 10.1002/jcph.303. Epub 2014 Apr 11.

PMID:
24729271
36.

Evaluation of the Mercy weight estimation method in Ouelessebougou, Mali.

Dicko A, Alhousseini ML, Sidibé B, Traoré M, Abdel-Rahman SM.

BMC Public Health. 2014 Mar 21;14:270. doi: 10.1186/1471-2458-14-270.

37.

Estimation of body weight in children in the absence of scales: a necessary measurement to insure accurate drug dosing.

Abdel-Rahman SM, Ridge A, Kearns GL.

Arch Dis Child. 2014 Jun;99(6):570-4. doi: 10.1136/archdischild-2013-305211. Epub 2014 Feb 26. No abstract available.

PMID:
24573883
38.

Pharmacokinetics of indomethacin in pregnancy.

Rytting E, Nanovskaya TN, Wang X, Vernikovskaya DI, Clark SM, Cochran M, Abdel-Rahman SM, Venkataramanan R, Caritis SN, Hankins GD, Ahmed MS.

Clin Pharmacokinet. 2014 Jun;53(6):545-51. doi: 10.1007/s40262-014-0133-6.

39.

Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia.

Friesen CA, Schurman JV, Colombo JM, Abdel-Rahman SM.

World J Gastrointest Pharmacol Ther. 2013 Nov 6;4(4):86-96. doi: 10.4292/wjgpt.v4.i4.86. Review.

40.

Validation of an improved pediatric weight estimation strategy.

Abdel-Rahman SM, Ahlers N, Holmes A, Wright K, Harris A, Weigel J, Hill T, Baird K, Michaels M, Kearns GL.

J Pediatr Pharmacol Ther. 2013 Apr;18(2):112-21. doi: 10.5863/1551-6776-18.2.112.

41.

Pediatric pharmacokinetics.

Wagner J, Abdel-Rahman SM.

Pediatr Rev. 2013 Jun;34(6):258-69. doi: 10.1542/pir.34-6-258. Review.

PMID:
23729775
42.

Evaluation of the Mercy TAPE: performance against the standard for pediatric weight estimation.

Abdel-Rahman SM, Paul IM, James LP, Lewandowski A; Best Pharmaceuticals for Children Act-Pediatric Trials Network.

Ann Emerg Med. 2013 Oct;62(4):332-339.e6. doi: 10.1016/j.annemergmed.2013.02.021. Epub 2013 Apr 17.

43.

Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Sullins AK, Abdel-Rahman SM.

Paediatr Drugs. 2013 Apr;15(2):93-117. doi: 10.1007/s40272-013-0017-5. Review.

PMID:
23529866
44.

Congenital cystic adenamatoid malformation: A case report.

Abdel Rahman SM, Bakhiet AH, Ibrahim SA, Ahmed AO, Sidahmed SA, Ahmed HA.

Sudan J Paediatr. 2013;13(2):57-60.

45.

Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group.

Abdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GT; Members of the BCS Task Force.

Clin Ther. 2012 Nov;34(11):S11-24. doi: 10.1016/j.clinthera.2012.09.014. Review.

46.

Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations.

James LP, Chiew A, Abdel-Rahman SM, Letzig L, Graudins A, Day P, Roberts D.

Eur J Clin Pharmacol. 2013 Apr;69(4):851-7. doi: 10.1007/s00228-012-1410-7. Epub 2012 Sep 28.

47.

Pediatric pharmacokinetics: human development and drug disposition.

Funk RS, Brown JT, Abdel-Rahman SM.

Pediatr Clin North Am. 2012 Oct;59(5):1001-16. doi: 10.1016/j.pcl.2012.07.003. Epub 2012 Aug 11. Review.

PMID:
23036241
48.

Genetic predictors of susceptibility to cutaneous fungal infections: a pilot genome wide association study to refine a candidate gene search.

Abdel-Rahman SM, Preuett BL.

J Dermatol Sci. 2012 Aug;67(2):147-52. doi: 10.1016/j.jdermsci.2012.05.003. Epub 2012 May 27.

49.

Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections.

Abdel-Rahman SM, Chandorkar G, Akins RL, Bradley JS, Jacobs RF, Donovan J, Benziger DP.

Pediatr Infect Dis J. 2011 Aug;30(8):712-4. doi: 10.1097/INF.0b013e31820fc8e1.

PMID:
21317681
50.

Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.

Abdel-Rahman SM, Newland JG, Kearns GL.

Paediatr Drugs. 2011 Feb 1;13(1):19-31. doi: 10.2165/11536950-000000000-00000. Review.

PMID:
21162598

Supplemental Content

Loading ...
Support Center